Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Capital Expenditures (2023 - 2025)

Incannex Healthcare (IXHL) has disclosed Capital Expenditures for 3 consecutive years, with $4000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures changed N/A to $4000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $8000.0 for FY2025, 97.11% down from the prior year.
  • Capital Expenditures hit $4000.0 in Q4 2025 for Incannex Healthcare, up from $2000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $221000.0 in Q3 2023 to a low of -$6000.0 in Q1 2024.
  • Historically, Capital Expenditures has averaged $47166.7 across 3 years, with a median of $3500.0 in 2024.